Logo for Awakn Life Sciences Corp.
AWKN

Awakn Life Sciences Corp.

Status
Active
Issued & Outstanding39,234,054
Reserved for Issuance18,449,293
Currency
CSE Index

About

Awakn Life Sciences Corp.

Listing date
February 13, 2024
Social

Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing medication-assisted treatments for addiction. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting approximately 51 million people in the US and key European markets and 285 million people globally for which the current standard of care is inadequate. Our goal is to provide breakthrough therapeutics to addiction sufferers in desperate need and our strategy is focused on commercializing our R&D pipeline across multiple channels.